Long‐term outcomes of a cohort of patients with pharmacoresistant neonatal epilepsy and negative brain <scp>MRI</scp>

Thibault Beretti(Hôpital de la Timone), Béatrice Desnous(Inserm), William Rozalen(Hôpital de la Timone), Florence Riccardi(Inserm), Laurent Villard(Inserm), Nathalie Villeneuve(Henri Gastaut Hospital), Géraldine Daquin(Hôpital de la Timone), Mathieu Milh(Inserm), Anne Lépine(Assistance Publique Hôpitaux de Marseille)

Epilepsia Open

August 30, 2025

10.1002/epi4.70126

Cited by 1

Related Papers

Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes

|Nature Genetics|2010|509

Diagnosis delay in West syndrome: misdiagnosis and consequences

|European Journal of Pediatrics|2012|88

Molecular and clinical descriptions of patients with <scp>GABA<sub>A</sub></scp> receptor gene variants (<i><scp>GABRA1</scp>, <scp>GABRB2</scp>, <scp>GABRB3</scp>, <scp>GABRG2</scp></i>): A cohort study, review of literature, and genotype–phenotype correlation

|Epilepsia|2022|80

Challenges and new perspectives of developmental cognitive EEG studies

|NeuroImage|2022|49

De novo mutations in CBL causing early-onset paediatric moyamoya angiopathy

|Journal of Medical Genetics|2017|41